| Schedule of Basic and Diluted Net Loss Per Share |
The
following table sets forth the computation of the Company’s basic and diluted net loss per share for:
| |
|
Three-months
ended June 30, 2019 (Unaudited) |
|
| |
|
Net
Loss (Numerator) |
|
|
Shares
(Denominator) |
|
|
Per
share
amount |
|
| Basic loss per share |
|
$ |
(1,081,694 |
) |
|
|
135,932,016 |
|
|
$ |
(0.01 |
) |
| Effect of dilutive
securities—Common stock options and warrants |
|
|
- |
|
|
|
- |
|
|
|
- |
|
| Diluted loss per share |
|
$ |
(1,081,694 |
) |
|
|
135,932,016 |
|
|
$ |
(0.01 |
) |
| |
|
Three-months
ended June 30, 2018 (Unaudited) |
|
| |
|
Net
Loss (Numerator) |
|
|
Shares
(Denominator) |
|
|
Per
share
amount |
|
| Basic loss per share |
|
$ |
(1,100,122 |
) |
|
|
122,975,014 |
|
|
$ |
(0.01 |
) |
| Effect of dilutive
securities—Common stock options and warrants |
|
|
- |
|
|
|
- |
|
|
|
- |
|
| Diluted loss per share |
|
$ |
(1,100,122 |
) |
|
|
122,975,014 |
|
|
$ |
(0.01 |
) |
| |
|
Six-months
ended June 30, 2019 (Unaudited) |
|
| |
|
Net
Loss (Numerator) |
|
|
Shares
(Denominator) |
|
|
Per
share
amount |
|
| Basic loss per share |
|
$ |
(2,217,114 |
) |
|
|
134,945,037 |
|
|
$ |
(0.02 |
) |
| Effect of dilutive
securities—Common stock options and warrants |
|
|
- |
|
|
|
- |
|
|
|
- |
|
| Diluted loss per share |
|
$ |
(2,217,114 |
) |
|
|
134,945,037 |
|
|
$ |
(0.02 |
) |
| |
|
Six-months
ended June 30, 2018 (Unaudited) |
|
| |
|
Net
Loss (Numerator) |
|
|
Shares
(Denominator) |
|
|
Per
share
amount |
|
| Basic loss per share |
|
$ |
(2,147,985 |
) |
|
|
122,825,595 |
|
|
$ |
(0.02 |
) |
| Effect of dilutive
securities—Common stock options and warrants |
|
|
- |
|
|
|
- |
|
|
|
- |
|
| Diluted loss per share |
|
$ |
(2,147,985 |
) |
|
|
122,825,595 |
|
|
$ |
(0.02 |
) |
|
| Schedule of Shares of Common Stock Equivalents Were Excluded from the Computation of Diluted Net Loss Per Share |
The
following outstanding shares of common stock equivalents were excluded from the computation of diluted net loss per share for
the periods presented because including them would have been antidilutive for the periods ended:
| |
|
June
30, 2019 |
|
|
June
30, 2018 |
|
| |
|
|
(Unaudited) |
|
|
|
(Unaudited) |
|
| Convertible notes |
|
|
1,250,000
|
|
|
|
- |
|
| Common stock options |
|
|
40,496,761 |
|
|
|
38,696,761 |
|
| Common stock
warrants |
|
|
100,958,031 |
|
|
|
127,434,122 |
|
| Total common
stock equivalents |
|
|
142,704,792 |
|
|
|
166,130,883 |
|
|